Latest News & Features
Patents
The lawyer behind a landmark ruling that reshaped prior art rules reveals how the decision will impact patent-opposition proceedings, influence trade secrets, and why strong legal arguments should never be lost in a “sea of weaker ones”, finds Marisa Woutersen. 18 July 2025
Careers
Three of the new shareholders have IP and life sciences expertise, bringing a commercial and policy focus to the firm. 17 July 2025
Trademarks
EU court insists geographical names must be available for their ‘natural descriptive use’ | INTA backs supermarket’s unsuccessful argument that EU law doesn’t prohibit country names as trademarks | Iceland Foods faces significant challenges if it expands further into EU markets. 16 July 2025
Patents
Following the UK government’s launch of its consultation on standard-essential patents, Tom Brazier of EIP raises concerns over proposals that appear “irrelevant” and “misguided”. 16 July 2025
Unified Patent Court
After almost 30 years as head of IP at Bayer, Jörg Thomaier is to retire and is handing the baton to Dorian Immler. Speaking to Sarah Speight, the pair explain what makes a good IP strategy, why the UPC is largely “useless” without SPCs, and more. 16 July 2025
Patents
LSPN experts from Goodwin Law, Invivyd, and New England Biolabs discuss the challenges of patent eligibility under 35 U.S.C. § 101 in life sciences innovation. The session explores strategies to address obstacles arising from recent court decisions and USPTO guidelines. 16 July 2025
Trademarks
The EU court’s refusal to register the iconic toy highlights its resolve to block monopolies on shapes with a technical function, says Sean Ibbetson of Bristows. 15 July 2025
Patents
Proposals aim to address a lack of transparency and uniformity in licensing standard-essential patents l Evidence shows an ‘asymmetry of pricing and information’ l Suggestions include a rate-determination track and mandatory disclosures for patent owners. 15 July 2025
Careers
LA-based partner has guided some of the industry’s “biggest names in headline-making deals”. 15 July 2025
Future of IP
This LSPN panel features experts from Maiwald, Regeneron, Vertex Pharmaceuticals, and Taylor Wessing discussing the impact of increased transparency requirements in clinical trials and their effects on the global patent system. The session focuses on recent regulatory changes, especially in Europe, and the challenges they present for IP protection. 14 July 2025
Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.